Adicet Bio, Inc. — Director's Dealing 2025

Apr 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2025-04-17

Reporting Person: Grissinger Michael (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-17	Stock Option (Right to Buy)	$0.5258	A	70200	Acquired	2035-04-16	Common Stock (70200)	Direct

Footnotes

F1: These shares shall vest in thirty-six (36) equal monthly installments following April 17, 2025; provided, however, that all vesting shall cease if the Reporting Person resigns from the Issuer's Board of Directors or otherwise ceases to serve as a director of the Issuer.